Diabetes Foundation, India   Report issue

Foundation Phase 4
Founded: New Dehli India

Organization Overview

First Clinical Trial
2009
NCT02027740
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Diabetes Foundation, India | National Diabetes Obesity and Cholesterol Foundation

Active Ingredients

Drugs in Phase 4 Trials (1)

sitagliptin (januvia) (1 trial)

Drugs in Other Trials (3)

almond (3 trials)

cinnamon (1 trial)

vitamin d3 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 4